BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 9636623)

  • 41. Metabolic control at two months to 4.5 years after pancreatic transplantation, with special reference to the role of cyclosporine.
    Tydén G; Brattström C; Gunnarsson R; Lundgren G; Ost L; Ostman J; Groth CG
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2294-6. PubMed ID: 3274510
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation.
    Ciancio G; Burke G; Viciana A; Ruiz P; Roth D; Khan TF; Montane B; Strauss J; Miller J
    Transplant Proc; 1998 Jun; 30(4):1536-7. PubMed ID: 9636624
    [No Abstract]   [Full Text] [Related]  

  • 43. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation.
    Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP
    Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation.
    Ciancio G; Lo Monte A; Buscemi G; Miller J; Burke GW
    Transpl Int; 2000; 13 Suppl 1():S191-4. PubMed ID: 11111994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results.
    Kaufman DB; Leventhal JR; Gallon LG; Parker MA
    Am J Transplant; 2006 Feb; 6(2):331-9. PubMed ID: 16426317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic long-term follow-up of functioning simultaneous pancreas-kidney transplantation versus pancreas transplantation alone: insights and limitations.
    Lauria MW; Figueiró JM; Machado LJ; Sanches MD; Nascimento GF; Lana AM; Ribeiro-Oliveira A
    Transplantation; 2010 Jan; 89(1):83-7. PubMed ID: 20061923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triple immunosuppression with tacrolimus in pediatric renal transplantation: single-center experience.
    Duzova A; Aki T; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bilginer Y; Demirkaya E; Bakkaloglu M
    Transplant Proc; 2008; 40(1):132-4. PubMed ID: 18261567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial.
    Land W; Malaise J; Sandberg J; Langrehr J;
    Transplant Proc; 2002 Aug; 34(5):1911-2. PubMed ID: 12176625
    [No Abstract]   [Full Text] [Related]  

  • 50. Steroid sparing with tacrolimus and mycophenolate mofetil in renal transplantation.
    Borrows R; Loucaidou M; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Am J Transplant; 2004 Nov; 4(11):1845-51. PubMed ID: 15476485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclosporine A blood levels predict acute rejections as well as cyclosporine A toxicity after simultaneous pancreas-kidney transplantation.
    Dawidson I; Ar'Rajab A; Lu C; Melone D; Provost D; Wheeler D
    Transplant Proc; 1994 Oct; 26(5):2757-8. PubMed ID: 7940868
    [No Abstract]   [Full Text] [Related]  

  • 52. Kidney-pancreas transplants: is it so difficult to start a program?
    Alonso A; Fernández C; Villaverde P; García R; Aguirrezabalaga J; Gómez M; Oliver J; Valdés F
    Transplant Proc; 2005 Apr; 37(3):1455-6. PubMed ID: 15866636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful pancreas-renal transplantation without anti-T-cell antibody induction.
    Shapiro ME; Abrams JM; Brown RS; Steinman TI; Strom TB
    Transplant Proc; 1995 Dec; 27(6):3087-8. PubMed ID: 8539857
    [No Abstract]   [Full Text] [Related]  

  • 54. Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression.
    Lee D; Keymeulen B; Hilbrands R; Ling Z; Van de Velde U; Jacobs-Tulleneers-Thevissen D; Maleux G; Lapauw B; Crenier L; De Block C; Mathieu C; Pipeleers D; Gillard P
    Transplantation; 2017 Sep; 101(9):2218-2227. PubMed ID: 27779572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreas transplantation after combined heart-kidney transplantation.
    Nguyen MT; Giannetti N; Cantarovich M; Cecere R; Chaudhury P; Paraskevas S
    Transplantation; 2011 Jan; 91(2):e13-4. PubMed ID: 21239958
    [No Abstract]   [Full Text] [Related]  

  • 56. Analysis of incidence and pattern of acute rejection episodes after simultaneous pancreas and kidney transplantation.
    Hiesse C; Paradis V; Benoît G; Kriaa F; Blanchet P; Bellamy J; Larue JR; Charpentier B
    Transplant Proc; 1997; 29(1-2):671-2. PubMed ID: 9123473
    [No Abstract]   [Full Text] [Related]  

  • 57. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
    Bechstein WO; Malaise J; Saudek F; Land W; Fernandez-Cruz L; Margreiter R; Nakache R; Secchi A; Vanrenterghem Y; Tydén G; Van Ophem D; Berney T; Boucek P; Landgraf R; Kahl A; Squifflet JP;
    Transplantation; 2004 Apr; 77(8):1221-8. PubMed ID: 15114089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Four-year results of pancreas transplantation in Taiwan.
    Chao SH
    Transplant Proc; 2000 Nov; 32(7):2467-8. PubMed ID: 11120247
    [No Abstract]   [Full Text] [Related]  

  • 60. Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol.
    Rahamimov R; Yussim A; After T; Lustig S; Bar-Nathan N; Shaharabani E; Shapira Z; Shabthai E; Mor E
    Transplant Proc; 2003 Mar; 35(2):653-4. PubMed ID: 12644082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.